Protein kinases: Getting NEKed for S6K activation  by Templeton, Dennis J
R596 Dispatch
Protein kinases: Getting NEKed for S6K activation
Dennis J. Templeton
The 70/85 kDa ribosomal protein S6 kinase is regulated
through the concerted actions of multiple phosphatases
and kinases. A newly identified S6 kinase kinase, NEK6,
appears to provide the penultimate activation step.
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Phosphorylation of the ribosomal subunit S6 is one of the
oldest known phosphorylation events in cell proliferation
control. Over the past three decades, two protein kinases
that can phosphorylate S6 have been characterized. One,
p90 ribosomal S6 kinase (p90 Rsk), is activated through
mitogen-activated protein (MAP) kinase pathways [1]. The
other, referred to as p70/p85 S6 kinase (S6K), has a more
convoluted mechanism of activation and inactivation. This
issue of Current Biology includes a report from Avruch and
colleagues [2] that adds yet another layer to the processes
that lead to S6K activation, involving a member of the
NIMA protein kinase family termed NEK6.
Biological function of S6K
Because it phosphorylates the ribosomal protein S6, S6K has
been suspected to be a regulator of translation [3]. S6K con-
trols expression of some specific mRNAs, particularly those
that contain 5′ terminal oligopyrimidine sequences [4], and
activation of S6K coincident with mitogenic stimulation may
be consistent with the general increase in protein synthesis
seen in replicating cells. The picture is complicated by the
fact that Saccharomyces cerevisiae S6 mutants that lack the
S6K-mediated serine phosphorylation site grow normally
[5]. But as no homolog of S6K has been identified in the
yeast genomes, translational control mechanisms in yeast
may differ substantially from mammalian cells.
A role for S6K in cell-cycle regulation was proposed
in the light of studies showing that neutralizing antibod-
ies against S6K injected into fibroblasts arrested these
cells in G1 [6]. Other evidence also supports the notion
that S6K is a cell-cycle regulator, for example the drug
rapamycin, which blocks S6K activation by inhibiting the
mTOR kinase (see below), is a potent inhibitor of cell-
cycle transition and induces G1 arrest. Rapamycin inhibits
expression of cyclin D3, resulting in inhibition of pRb
and p107 phosphorylation [7], leading to the hypothesis
that S6K, or at least mTOR, may activate cyclin D3 tran-
scription or translation. 
In addition to cell cycle, S6K also appears to control cell
size: targeted disruption of the S6K1 gene results in viable,
but small mice that apparently survive owing to expression
of S6K-related kinases [8]. Similarly, inactivation of the
homolog of S6K in Drosophila leads to reduction in cell
growth — that is, smaller cells rather than fewer cells [9].
Control of cell size appears to be consistent with a function
of S6K in translational control, but is harder to reconcile
with a role for S6K in cell-cycle control. 
Downstream regulation of S6K by protein phosphatases
S6K activity can be completely quenched in cells treated
with the drug rapamycin [10,11] or in cells subjected to
amino acid starvation [12], or osmotic shock [13]. While
some reports have concluded that rapamycin blocks an
upstream activation process, other reports have shown that
each of these inhibitory stimuli activates a protein phos-
phatase that results in rapid dephosphorylation of specific
residues on S6K and thereby loss of S6K activity. Curi-
ously, while S6K has been found associated with the PP2A
phosphatase [14], the PP2A inhibitor okadaic acid does not
block S6K inhibition mediated by rapamycin or osmotic
shock. However, the broad spectrum phosphatase inhibitor
calyculin A reverses the negative effect of all of these
inhibitory stimuli [12,13]. 
This scenario is reminiscent of the function of rapamycin
in regulating phosphatase function in yeast. In both
mammalian cells and yeast, rapamycin binds to the pep-
tidyl-prolyl isomerase FKBP12, which then targets a
kinase termed target of rapamycin or TOR [15]; mam-
malian forms are also known as FRAP or RAFT. In yeast,
TOR phosphorylates TAP42, a docking protein for PP2-
related phosphatases [16]. The mammalian homolog of
TAP42 is termed alpha 4, which has been shown to bind
PP2A, PP4, and PP6 [17]. Attractive models can be drawn
in which rapamycin-mediated inhibition of mTOR liber-
ates active phosphatases from alpha 4 that then lead to
S6K inhibition. 
Upstream regulation of S6K by protein kinases
S6K is regulated by several distinct kinases or kinase fami-
lies. Figure 1 summarizes the known S6K phosphorylation
sites. The full-length S6K polypeptide is inhibited by
autoregulatory sequences flanking the kinase domain at
both the amino terminus and carboxyl terminus [18,19]. A
portion of the carboxy-terminal regulatory domain is some-
times called the pseudosubstrate domain by analogy to
sequences that contribute to regulation of protein kinase C
(PKC). This sequence, between codons 434 and 452, is
multiply phosphorylated in cells stimulated with mito-
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gens, and this phosphorylation contributes to the multiple
slower-migrating bands of S6K seen on SDS gels. The Erk
MAP kinase, and probably other MAP kinases, appear to
be responsible for phosphorylation of these sequences
[20]. Expression in mammalian cells of deletion mutants
lacking these inhibitory sequences results in a tremen-
dously activated kinase that is relatively resistant to the
effects of rapamycin [18,19]. These truncated kinases are
not active when expressed in bacteria, however, demon-
strating a requirement for mammalian kinases that target
the residual catalytic domain of S6K.
Several additional phosphorylation sites of S6K have been
identified through peptide mapping and phosphorylation
site mutagenesis. Threonine 252, which lies within the
activation loop, is required for kinase activity [21]: for
many other kinases, an activating phosphorylation event
in the corresponding domain is similarly required. The 3-
phosphoinositide-dependent protein kinase PDK1 strongly
phosphorylates this site, and contributes to activation of
S6K [22]. The identification of PDK1 as a required activa-
tor of S6K serves to explain the sensitivity of S6K to phos-
phatidylinositol 3-kinase inhibitors such as wortmannin.
To make the situation more complex, PDK1 is poorly able
to activate S6K unless residues other than Thr252 are
phosphorylated beforehand [22]. This is true even using
deletion mutants lacking the pseudosubstrate autoin-
hibitory domains between codons 434 and 452. For PDK1
to efficiently phosphorylate Thr252, prior phosphorylation
at the distal sites Ser394, Thr412 and/or Thr427 is required.
These residues lie within a hydrophobic sequence that is
similar to a region in the PKC and PKB/Akt kinases, which
are also activated by phosphorylation in this domain. Of
these sites, phosphorylation of S6K residue Thr412 appears
to be the most significant for allowing PDK1 to phospho-
rylate within the activation loop.
The unanswered question to this point is, what kinase
phosphorylates Thr412? Both mTOR and PDK1 have been
reported to be able to phosphorylate this residue, [22,23],
although the rate of phosphorylation of Thr412 by PDK1
preparations is much lower than of Thr252. Additional evi-
dence for the role of PDK1 in regulating phosphorylation
of Thr412 is that transfection of active or inhibitory alleles
of PDK1 affect Thr412 phosphorylation [24]. Also, mouse
cells lacking PDK1 [25] do not phosphorylate Thr412 of
S6K (referred to as Thr389 in that reference), and also lack
phosphorylation of the analogous Ser473 residue in
PKB/Akt. Case closed? 
NEK6 as an S6K activator
The paper from Avruch’s lab [2] points to the culprit
in phosphorylation of Thr412 as being a homolog of the
NIMA kinase, termed NEK6. This work describes the
purification of a protein that can activate a form of S6K
that lacks the autoinhibitory domains. The purified S6K-
activating fractions contained NEK6 and the closely
related protein NEK7. NEK6 protein expressed from
cDNAs phosphorylated Thr412 of S6K directly, and syn-
ergized with PDK1 in in vitro activation of S6K, particu-
larly when NEK6 was incubated with S6K before PDK1.
Other sites of S6K phosphorylation by NEK6 remain
uncharacterized.
Figure 1
S6K domain structure and phosphorylation
sites. Two isoforms of p70/p85 S6K are
known; the codon numbering of 85 kDa S6K
is used in this review, the 70 kDa form
initiates at codon 24. The catalytic domain
(pink) is flanked by regulatory domains
(green) that when deleted result in high
catalytic activity. A hydrophobic domain
(similar to domains in PKB and PKC) that is
required for catalytic activity lies distal to the
kinase domain and is shown in blue. Within
the inhibitory domains, codon Ser40 is
phosphorylated by casein kinase 2, but does
not appear to contribute to S6K activation.
Five Ser–Pro/Thr–Pro codon pairs between
434 and 452 are phosphorylated by MAP
kinase(s), which promote S6K activation.
Within the kinase activation loop, codon
Thr252 is required for S6K activity; this
residue is phosphorylated by PDK1. Within
the blue flanking domain, codons Ser394,
Thr412, and Thr427 are phosphorylated; of
these codon Thr412 appears to be most
significant in promoting S6K activation.
Avruch’s paper [2] points to NEK6 as being
responsible for Thr412 phosphorylation. 
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The involvement of NIMA-related kinases in growth signal
transduction is somewhat surprising. NIMA was first identi-
fied in Aspergillus as a gene normally expressed in G2, which
when overexpressed caused chromatin condensation and
premature M phase entry [26]. The NIMA kinase associates
with mitotic spindles and phosphorylates the mitotic
histone H3 [27] possibly explaining the observed chromatin
condensation. Seven NIMA-related kinases — termed
NEKs — have been identified in human cells. The best-
characterized of these is NEK2, which is associated with
centrosomes and appears to induce centrosomal division
[28]. This is consistent with a role in the cell cycle similar to
the original NIMA kinase. No biochemical characterization
of other NEKs has been published to date, although the
chromosomal location of NEK6 has been reported [29]. The
work from Avruch and colleagues provides the first evi-
dence for a physiological substrate for NEK6.
Open questions
The identification of the NEK kinase family as upstream
regulators of S6K adds a new layer of complexity to its regu-
lation (see Figure 2). Activation of S6K now appears to
require the coordinated action of at least three kinase fami-
lies, possibly casein kinase 2, then the MAP kinases, the
NEKs, and PDK1 sequentially. As the regulation of NEK6
itself is completely unknown, the current finding opens the
possibility that unidentified physiological pathways may
contribute to S6K activation. Left unexplained by this
model is the absence of Thr412 phosphorylation in cells
lacking PDK1 [25]. Perhaps PDK1 itself provides a required
upstream event in activation of NEK6? Like S6K, PKB/Akt
is also regulated by PDK1-mediated phosphorylation within
the activation loop and by phosphorylation within the
hydrophobic domain at a residue corresponding to Thr412
of S6K. Perhaps NEK6 or other NEK homologs play a role
in activating PKB/Akt? The identification of NEK6 as an
activator of S6K also raises the question of whether it might
explain other S6K regulatory events. Since the S6K mutant
Thr412Glu is at least partially resistant to the effects of
rapamycin [30], perhaps the rapamycin-activated phos-
phatase targets NEK6 rather than S6K itself?
These questions will probably be resolved soon. While its
history predates most of its mitogenically activated kinase
peers, unraveling the tangled pathways of S6K activation
continues to reveal more at the core. 
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Figure 2
Model of sequential activation of S6K by
different kinase families. Unphosphorylated
S6K is held in the inactive state by inhibitory
domains flanking the catalytic domain.
Phosphorylation on Ser40 by casein kinase 2
(CK2, step 1) appears to be constitutive and
is not absolutely required for activity.
Phosphorylation within the carboxy-terminal
autoinhibitory domain (step 2) is
accomplished by MAP kinases or other
proline-directed kinases. Phosphorylation of
residue Thr412 (step 3) is accomplished by
NEK6/7. The role and regulation of the
adjacent sites Ser394 and Thr427 remains to
be determined. Ultimately, PDK1
phosphorylates residue Thr252 within the
activation loop, completing the activation
process. See text for references. N, amino
terminus; C, carboxyl terminus.
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